Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Investview (INVUP) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Investview (INVUP) over the last 16 years, with Q3 2025 value amounting to $15.1 million.

  • Investview's Cash & Equivalents fell 3824.86% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.1 million, marking a year-over-year decrease of 3824.86%. This contributed to the annual value of $22.5 million for FY2024, which is 743.79% up from last year.
  • According to the latest figures from Q3 2025, Investview's Cash & Equivalents is $15.1 million, which was down 3824.86% from $16.2 million recorded in Q2 2025.
  • Investview's Cash & Equivalents' 5-year high stood at $31.0 million during Q4 2021, with a 5-year trough of $5.4 million in Q1 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $20.6 million (2021), whereas its average is $20.2 million.
  • As far as peak fluctuations go, Investview's Cash & Equivalents skyrocketed by 382897.79% in 2021, and later crashed by 3824.86% in 2025.
  • Quarter analysis of 5 years shows Investview's Cash & Equivalents stood at $31.0 million in 2021, then crashed by 34.45% to $20.3 million in 2022, then grew by 2.93% to $20.9 million in 2023, then rose by 7.44% to $22.5 million in 2024, then plummeted by 32.79% to $15.1 million in 2025.
  • Its Cash & Equivalents was $15.1 million in Q3 2025, compared to $16.2 million in Q2 2025 and $17.5 million in Q1 2025.